Clinical Trials
2 trialsNCT00024674 2014-11-14
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: Continuous Infusion for 10 Days
INSYS Therapeutics Inc
Phase 1 Withdrawn
NCT00024687 2014-11-14
Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses
INSYS Therapeutics Inc
Phase 1 Withdrawn